1 / 58

Country Presentation: State of Progress of the TDI by country in 2004

Country Presentation: State of Progress of the TDI by country in 2004. Annual Expert Meeting on Treatment Deamnd Indicator, 22-23 September 2004 – EMCDDA Lisbon. Name Martin Busch. Austria (1). National Expert:. Expert based in NFP:. Yes. N. staff working on TDI:. 3 (parttime).

clyde
Télécharger la présentation

Country Presentation: State of Progress of the TDI by country in 2004

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Country Presentation:State of Progress of the TDI by country in 2004 • Annual Expert Meeting on Treatment Deamnd Indicator, 22-23 September 2004 – EMCDDA Lisbon

  2. Name Martin Busch Austria (1) • National Expert: • Expert based in NFP: Yes • N. staff working on TDI: 3 (parttime) • Validation study conducted: • No National Working Group in place • Yes – several groups

  3. No / Poor / Sufficient / Good • /Now/ /___/ /___/ /Future/ • /Now/ /___/ /___/ /Future/ /___/ /___/ /Now/ /___/ • /Now/ /___/ /____/ /Future/ • /Now/ /___/ /___/ /Future/ /____/ /___/ /___/ /___/ Austria (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • The concept of primary drug is not applyable – different solutions are under discussion Other important issues

  4. Tinneke DE CLERCQ, Francis SARTOR Belgium (1) National Experts: Expert based in NFP: Yes N. staff working on TDI: 1 Validation study conducted: • No National Working Group in place • Yes

  5. Belgium (2) Types of centre covered: - No national, meaningful, figures can be derived from the more than 10 different systems reporting treatment data, including or not treatment demands. - The global coverage of the different types of treatment centres present in the systems, is not known in the majority of the systems. It’s moreover different according to availability of certain types of treatment centres, different interpretations of the inclusion criteria of the EMCDDA protocol and pragmatic reasons. • Compatibility with the EMCDDA Protocol: • Differences between different treatment reporting systems: types of treatment centres, external coverage, internal coverage, multiple countings, variables and continuity of registration •  variability of compatibility according to the treatment reporting system • Drafting of a Belgian version of the EMCDDA protocol • Future steps:- development and implementation of a common unique identifier for Belgium • - detailed inventory + information on the « registration status » of the different treatment centres Other important issues:

  6. Belgium (3) Project: Belgian version of the EMCDDA protocol: - AIM: To adapt the EMCDDA protocol to the Belgian situation and todevelop in this way a theoretical framework for uniform and standardized data collection, as a first step towards reliable and comparable national figures for Belgium - EXPERIENCED DIFFICULTIES: * definition and classification of the types of treatment centres to include * interpretation of the options of the variable « labour status » * determination of the primary drug - NEXT STEPS: * approval by the Health Policy Drug Cel * approval by the Interministerial Conference on Health * operationalisation

  7. Momtchil Vassilev Bulgaria (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: 3 persons – not only on TDI • Validation study conducted: • No National Working Group in place • Yes

  8. No / Poor / Sufficient / Good • /___/ / X / /___/ /___/ • /___/ /___/ / X / /___/ • / X / /___/ /___/ /___/ • / X / /___/ /___/ /___/ • / X / /___/ /___/ /___/ • /___/ /___/ /___/ /___/ Bulgaria (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Fully compatible • Compatibility with the EMCDDA • Protocol • Data collection is based on a special Registration Form / Questionnaire, filled in by doctors, psychologists, nurses etc. Other important issues

  9. Name _Ioanna Yiasemi Cyprus (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: N. /_2__/ • Validation study conducted: • No National Working Group in place • No

  10. No / Poor / Sufficient / Good • /_7__/ /___/ /___/ /_x__/ • /__2_/ /___/ /___/ /__x_/ • /__0_/ /__x_/ /___/ /___/ • /_0__/ /___/ /___/ /_x__/ • /__0_/ /_x__/ /___/ /___/ • /__0_/ /___/ /___/ /_x__/ Cyprus (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • 51-90% • Compatibility with the EMCDDA • Protocol • The EMCDDA Protocol has been implemented in April, 2004. Other important issues

  11. Name Bela Studnickova Czech Republic (1) • National Expert: No – Drug Epidemiology Headquarters HS • Expert based in NFP: • N. staff working on TDI: N. /4/ • Validation study conducted: • No National Working Group in place • Yes - in NFP

  12. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_X__/ • /___/ /___/ /___/ /_X__/ • /_X__/ /___/ /___/ /___/ • /___/ /___/ /___/ /_X__/ • /___/ /_X__/ /___/ /___/ • /_X__/ /___/ /___/ /___/ Czech Republic (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol = 1. • State-wide coverage (more then 300 T/C centres) • Data about problematic drug users (EMCDDA definition) and other treated drug users (canna-binoids, hallucinogens, volatile solvents, other medicaments users) Other important issues

  13. Eva Hammerby Denmark (1) • National Expert: • Expert based in NFP: • No (but in the same building) • N. staff working on TDI: N. 1 • Validation study conducted: • No National Working Group in place • Yes

  14. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_x_/ • /___/ /___/ /___/ /_x_/ • /___/ /___/ /___/ /___/ • /_x_/ /___/ /___/ /___/ • /_x_/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ Denmark (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • (except no information on referral) • Compatibility with the EMCDDA • Protocol • ____________________________ ____________________________ ____________________________ Other important issues

  15. Ave Talu Estonia (1) • National Expert: • Expert based in NFP: Estonian Drug Monitoring Centre At the moment only TDI expert is dealing with legal and technical aspects of DTD Registry; since January 2005, in total 3 persons • N. staff working on TDI: • Validation study conducted: • Yes/No National Working Group in place • Yes/No

  16. No / Poor / Sufficient / Good • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ Estonia (1) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • By the Development Plan of Health Registries the Treatment Demand Registry must be established on 1st January 2005. EDMC will be responsible for keeping the registry. Other important issues

  17. Airi Partanen Finland (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: 1,5 person year/4 persons • Validation study conducted: • No National Working Group in place • Yes

  18. No / Poor / Sufficient / Good • /___/ /___/ /_x_/ /___/ • /___/ /___/ /_x_/ /___/ • /___/ /_x_/ /___/ /___/ • /___/ /_x_/ /___/ /___/ • /___/ /___/ /_x_/ /___/ • /___/ /_x_/ /___/ /___/ Finland (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • 51-90% • Compatibility with the EMCDDA • Protocol • Voluntary, anonymous, statistical data collection Other important issues

  19. VAISSADE Laure PALLE Christophe France (1) • National Expert: Yes • Expert based in NFP: • N. staff working on TDI: 0,8 • Validation study conducted: • No National Working Group in place • Yes

  20. No / Poor / Sufficient / Good • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ France (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • Yes • OPEMA_____________________ ____________________________ ____________________________ Other important issues

  21. Name Simon Germany (1) • National Expert: • Expert based in NFP: • Yes 1 in NFP • N. staff working on TDI: N. 3 • Validation study conducted: • Yes National Working Group in place • Yes

  22. No / Poor / Sufficient / Good • /___/ /___/ 707 /___/ • /___/ /___/ 106 /___/ • /___/ /___/ 0 /___/ • /___/ /___/ 0 /___/ • /___/ /___/ 0 /___/ • /___/ /___/ 0 /___/ Germany (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • Compatibility with the EMCDDA • Protocol • Special evaluation of Prison based and low threshold units planned for 2004 Other important issues

  23. Katerina Kontogeorgiou • Maria Pouloudi Greece (1) • National Expert: • Expert based in NFP: Yes 3: - Project manager - Statistician - Secretary • N. staff working on TDI: “Reliability of drug dependents’ self-reports”, Kokkevi A., Richardson C., Palermou B. and Leventakou V., Drug and Alcohol Dependence 45 (1997) p.55-61 • Validation study conducted: • Sub-Task 3.1. « To improve the reliability of data collected by treatment demand reporting systems » July 1997, UMHRI National Working Group in place • No

  24. No / Poor / Sufficient / Good • √ • √ • √ • √ • √ Greece (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • Compatibility with the EMCDDA • Protocol • More than 90% national coverage • Great changes in the reporting system make trend analysis difficult • Individual questionnaires • Double counting controlled Other important issues

  25. Dr József RÁCZ Hungary (1) • No, Institute for Psychology, Hungarian Academy of Sciences • National Expert: • Expert based in NFP: 1 person • N. staff working on TDI: • Validation study conducted: • No National Working Group in place • Yes

  26. No / Poor / Sufficient / Good • /___/ x/___/ /___/ • /___/ x/___/ /___/ • x/___/ /___/ /___/ • x/___/ /___/ /___/ • x/___/ /___/ /___/ • /___/ x /___/ /___/ Hungary (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • EMCDDA TDI Protocol is under implementation Other important issues

  27. Name Jean Long Ireland (1) • Yes, Drug Misuse Research Division, Health Research Board, Dublin • National Expert: • Expert based in NFP: • N. staff working on TDI: N. /2.5/ • Validation study conducted: • Yes, Opiate users attending methadone services National Working Group in place • Yes, Not specific to TDI but progress included

  28. No / Poor / Sufficient / Good • /___/ /___/ /x/ /___/ • /___/ /___/ /x/ /___/ • /___/ /x/ /___/ /___/ • /___/ /___/ /x/ /___/ • /x/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ Ireland (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, from 2004 fully compatible • Compatibility with the EMCDDA • Protocol • ____________________________ ____________________________ ____________________________ Other important issues

  29. NAME Aldo Polettini Italy (1) • National Expert: • Expert based in NFP: • No . University of Pavia • N. staff working on TDI: N. /46/ (central and regional level) • Validation study conducted: • Yes National Working Group in place • Yes

  30. No / Poor / Sufficient / Good • /___/ /___/ /_X_/ /___/ • /___/ /_X_/ /___/ /___/ • /___/ /_X_/ /___/ /___/ • /_X__/ /___/ /___/ /___/ • /___/ /___/ /_X_/ /___/ • /___/ /___/ /_X_/ /___/ Italy (2) • Types of centre covered: • Outpatient • Inpatient • GPs (see foot notes) • Low Threshold Agencies (see foot notes) • Units in Prison (see foot notes) • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol) • Reporting of treatment data in line with the TDI protocol only occurs in some Regions. In these Regions it is fully compatible and extension to other Italian Regions is in process. Other important issues:Notes

  31. Name Ieva Matisone Latvia (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: N. 2 • Validation study conducted: • Yes National Working Group in place • No

  32. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_+_/ • /___/ /___/ /___/ /_+_/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ Latvia (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • ____________________________ ____________________________ ____________________________ Other important issues

  33. Name Alain ORIGER Luxembourg (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: 2 • Validation study conducted: • No National Working Group in place • Yes

  34. No / Poor / Sufficient / Good • X • X • X • X • X • X Luxembourg (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • Compatibility with the EMCDDA • Protocol • A difference should be made between ‘ ITEM COMPATIBILITY ’ and ‘  CATEGORIES OF ANSWERS COMPATIBILITY ’ Other important issues

  35. Name : Anna Girard __________ Malta (1) • National Expert: • Yes/No (where?) Yes • _Ministry for the Family and Social Solidarity • Expert based in NFP: • N. staff working on TDI: N. / 5 / • Validation study conducted: • Yes/No National Working Group in place • Yes/No

  36. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_x_/ • /___/ /___/ /___/ /_x_/ • /_x_/ /___/ /___/ /___/ • /_x__/ /___/ /___/ /___/ • /___/ /___/ /___/ /_x_/ • /___/ /___/ /___/ /___/ Malta (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • ____________________________ ____________________________ ____________________________ Other important issues

  37. Anton W. Ouwehand Netherlands (1) • National Expert: • Expert based in NFP: • No based in IVZ, in coop. NFP • N. staff working on TDI: • including national system LADIS N. /6 • Validation study conducted: • Yes in 1997 • Yes, Epid.workgroup NFP National Working Group in place

  38. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_xx_/ • /___/ /_xx_*/ /___/ /___/ • /_xx_/ /___/ /___/ /___/ • /___/ /___/ /___/ /_xx_ • /___/ /___/ /_xx_/ /___/ • /___/ /___/ /___/ /_xx_/ Netherlands (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • Compatibility with the EMCDDA • Protocol • _*In 2005 all inpatient clinics information will be involved in LADIS. From 2006 reporting system will be covering 100 % of addiction treatment (except GP ’s) Other important issues

  39. Erik Iversen Norway (1) • National Expert: • No : Bergen Clinics Foundn. • Expert based in NFP: • N. staff working on TDI: N. / 4 (13+) / • Validation study conducted: • No National Working Group in place • Yes

  40. No / Poor / Sufficient / Good • /___/ /_X_/ /_X_/ /___/ • /___/ /___/ /_X_/ /_X_/ • /_X_/ /___/ /___/ /___/ • /___/ /_X_/ /_X_/ /___/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ Norway (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • 1 and 4: Yes, fully compatible, but not compatible due to data on aggregated level. • Compatibility with the EMCDDA • Protocol • System is under revision, linked to a national reform placing the addiction sector within the specialist health care system Other important issues

  41. Name:Boguslawa Bukowska Janusz Sieroslawski Poland (1) • National Experts: • Expert based in NFP: • Yes/No (where?) _____ • N. staff working on TDI: N. /2 - up to now/ • Validation study conducted: • Yes/No National Working Group in place • Yes/No

  42. No / Poor / Sufficient / Good • /_0__/ /___/ /___/ /___/ • /_0__/ /___/ /___/ /___/ • /_0__/ /___/ /___/ /___/ • /_0__/ /___/ /___/ /___/ • /_0__/ /___/ /___/ /___/ • /_0__/ /___/ /___/ /___/ Poland (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • TDI according to EMCDDA standards will be implemented in Poland in 2005. (Program Transition Facility - light twinning)________________________ Other important issues

  43. Name _Fernanda Feijão Portugal (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: N. 3 • Validation study conducted: • No National Working Group in place • Yes

  44. No / Poor / Sufficient / Good • /___/ /___/ /_X_/ /___/ • /_X__/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /_ X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ Portugal (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • 10-50% • Compatibility with the EMCDDA • Protocol • TDI depends on the Treatment National Information System for Drug Users Other important issues

  45. Name: Madi SURUGIU, MD Romania (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: N. /__2_/ • Validation study conducted: • No National Working Group in place • Yes

  46. No / Poor / Sufficient / Good • /___/ /___/ /_X__/ /___/ • /___/ /__X_/ /___/ /___/ • /__X_/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /__X_/ /___/ /___/ /___/ • /__X_/ /___/ /___/ /___/ Romania (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • The monitoring system will be improved starting with 2004 and the RMCDDA will develop its own database Other important issues

  47. Name: Imrich Steliar Slovakia (1) • National Expert: • Expert based in NFP: • Yes • N. staff working on TDI: N. /1+4*/ *staff working on data collection and processing at the Institute of Health Inf.&Statistics • Validation study conducted: • No National Working Group in place • No

  48. No / Poor / Sufficient / Good • /___/ /___/ /___/ /_X_/ • /___/ /___/ /___/ /_X_/ • /_X_/ /___/ /___/ /___/ • /_X_/ /___/ /___/ /___/ • /___/ /___/ /___/ /_X_/ • /___/ /___/ /___/ /_X_/ Slovakia (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others (Min.of transport.-hosp. of railways) • Yes, fully compatible • 51-90% • 10-50% • No • Compatibility with the EMCDDA • Protocol • ____________________________ ____________________________ ____________________________ Other important issues

  49. Miljana Vegnuti Slovenia (1) • National Expert: Yes • Expert based in NFP: 4 • N. staff working on TDI: • Validation study conducted: • No National Working Group in place • Yes

  50. No / Poor / Sufficient / Good • /1 / /___/ /___/ /18 / • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /___/ • /___/ /___/ /___/ /6 / • /___/ /___/ /___/ /___/ Slovenia (2) • Types of centre covered: • Outpatient • Inpatient • GPs • Low Threshold Agencies • Units in Prison • Others • Yes, fully compatible • Compatibility with the EMCDDA • Protocol • The evaluation of treatment programmes in Slovenia will start next year as soon as the appropriate data on low threshold agencies will be available_________________________ ____________________________ ____________________________ Other important issues

More Related